Results of organ-preserving treatment for renal-cell carcinoma
https://doi.org/10.17650/1726-9776-2007-3-1-18-24
Abstract
Objective: The immediate and long-term results of nephron-sparing treatment for renal-cell carcinoma (RCC) were retrospectively assessed. The impact of several prognostic factors on treatment results was analyzed.
Material and Methods: All cases of partial nephrectomy in RCC performed at the N.N. Alexandrov Research Institute of Oncology and Medical Radiology in 1993 and 2005 were collected. The data on the patients' deaths were selected from the Byelorussian cancer register. Mono- and multivariant analyses were made by using the Kaplan-Meier method and the Cox proportional hazard model.
Results: A total of 298 operations were performed in 292 patients, 271 being in RCC. Complications developed in 5.5% of the patients. The follow-up averaged 30.0±28.2 months. A local relapse was diagnosed in 4 (1.5%) patients. Five- and 10-year crude survival rate was 87.2%. The results of partial nephrectomy in pT3a tumors more than 4 cm were found significantly worse than those in pT1-2 and pT3a 4 cm or less (p = 0.03). The Cox proportional hazard model revealed the significance of pT, size and grade combination (p = 0.03). Three groups of patients were formed by the significantly different 10-year survival rates.
Conclusion: Partial nephrectomy is a safe and effective treatment for localized RCC. Elective operation can be performed in patients with T3a RCC 4 cm or less. It is possible to divide patients into 3 prognostic groups with different survival rates in relation to the treatment results in pT, tumour size and grade.
About the Authors
O. G. Sukonko
N.N. Alexandrov Research Institute of Oncology and Medical Radiology
Belarus
Minsk
Belarus
Minsk
A. I. Rolevich
N.N. Alexandrov Research Institute of Oncology and Medical Radiology
Belarus
Minsk
Belarus
Minsk
S. A. Krasnyi
N.N. Alexandrov Research Institute of Oncology and Medical Radiology
Belarus
Minsk
Belarus
Minsk
S. L. Polyakov
N.N. Alexandrov Research Institute of Oncology and Medical Radiology
Belarus
Minsk
Belarus
Minsk
P. S. Kushnirenko
N.N. Alexandrov Research Institute of Oncology and Medical Radiology
Belarus
Minsk
Belarus
Minsk
References
1. Поляков С.М., Левин Л.Ф., Шебеко Н.Г. Злокачественные новообразования в Беларуси 1995—2004. Под ред. А.А. Граковича, И.В. Залуцкого. Минск, БелЦМТ; 2005.
2. Hock L.M., Lynch J., Balaji K.C. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002;167:57—60.
3. Tate R., Iddenden R., Harnden P. et al. Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978—1997. Eur J Cancer 2003;39:961—7.
4. Vallancien G., Torres L.O., Gurfinkel E et al. Incidental detection of renal tumors by abdominal ultrasonography. Eur Urol 1990;18:94—6.
5. Robson C.J., Churchill B.M., Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297.
6. Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001;166:6—18.
7. Belldegrun A., Tsui K.H., deKernion J.B., Smith R.B. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 1999;17:2868—75.
8. Campbell S.C., Novick A.C., Streem S.B. et al. Complications of nephron-sparing surgery for renal tumors. J Urol 1994;151:1177—80.
9. Lerner S.E., Hawkins C.A., Blute M.L. et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996;155:1868—73.
10. Van Poppel H., Bamelis B., Oyen R., Baert L. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol 1998;160:674—8.
11. Hafez K.S., Fergany A.F., Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999;162:1930—3.
12. Lee C.T., Katz J., Shi W. et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 2000;163:730—6.
13. Patard J.-J., Shvarts O., Lam J.S. et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004;171:2181—5.
14. Аляев Ю.Г., Крапивин А.А. Локализованный и местно-распространенный рак почки: нефрэктомия или резекция? Онкоурология. 2005;(1):10—5.
15. Fergany A.F., Hafez K.S., Novick A.C. Longterm results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163:442—5.
16. Hafez K.S., Novick A.C., Butler B.P. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol 1998;159:1156—60.
17. Clark P.E., Schover L.R., Uzzo R.G. et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology 2001;57:252—6.
18. Lau W.K., Blute M.L., Weaver A.L. et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000;75:1236—42.
19. McKiernan J., Simmons R., Katz J., Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002;59:816—20.
Review
For citations:
Sukonko O.G., Rolevich A.I., Krasnyi S.A., Polyakov S.L., Kushnirenko P.S. Results of organ-preserving treatment for renal-cell carcinoma. Cancer Urology. 2007;3(1):18-24. (In Russ.) https://doi.org/10.17650/1726-9776-2007-3-1-18-24
Views:
285
Email this article 